5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T62434 | HBV-IN-10 | ||
HBV-IN-10 is an isomer of compound 6 (WO2021204258A1). Compound 6 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.1 μM < EC50 ≤ 1 μM). | |||
T62433 | (5S,8R)-HBV-IN-10 | ||
(5S,8R)-HBV-IN-10 is an isomer of compound 6 (WO2021204258A1). Compound 6 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.1 μM< EC50≤1 μM). | |||
T77714 | HBV-IN-37 | HBV | |
HBV-IN-37 is an HBV inhibitor with an EC50 value of 10 μM and can be used for hepatitis B disease-related research. | |||
T62247 | HBV-IN-9 | ||
HBV-IN-9 (example 20) is a potent inhibitor of HBsAg (HBV surface antigen) with an IC50 value of 10 nM. HBV-IN-9 (example 20) is also an inhibitor of HBV DNA replication with an IC50 value of 0.15 nM. | |||
T11549 | Helioxanthin 8-1 | Helioxanthin analogue 8-1 | Others |
Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM. |